Cargando…

Caveolin-1 expression in benign and malignant lesions of the breast

BACKGROUND: Caveolin-1 is thought to have an important impact on both signal transduction and mediation of intracellular processes. Furthermore, it has been suggested that Caveolin-1 may contribute to certain steps of carcinogenesis in various types of cancer. We examined the potential clinical rele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liedtke, Cornelia, Kersting, Christian, Bürger, Horst, Kiesel, Ludwig, Wülfing, Pia
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082377/ https://www.ncbi.nlm.nih.gov/pubmed/17915016 http://dx.doi.org/10.1186/1477-7819-5-110

Ejemplares similares

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ
por: Götte, Martin, et al.
Publicado: (2007)

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
por: Radke, I, et al.
Publicado: (2006)

Expression of Endothelin-A-Receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer
por: Wülfing, P, et al.
Publicado: (2004)

The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions
por: Terry, G, et al.
Publicado: (2007)

Expression of tropomyosin isoforms in benign and malignant human breast lesions.
por: Franzén, B., et al.
Publicado: (1996)

Egfr Amplification Specific Gene Expression in Phyllodes Tumours of the Breast
por: Agelopoulos, Konstantin, et al.
Publicado: (2007)

Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ
por: Wülfing, P, et al.
Publicado: (2005)

Glutathione localisation in benign and malignant human breast lesions.
por: Murray, G. I., et al.
Publicado: (1987)

Automated Classification of Benign and Malignant Proliferative Breast Lesions
por: Radiya-Dixit, Evani, et al.
Publicado: (2017)

Immunohistochemical expression of interleukin-17 and hormonal receptors in benign and malignant breast lesions
por: Ali, Eman Taha, et al.
Publicado: (2020)

Expression, Localization, and Phosphorylation of Akt1 in Benign and Malignant Thyroid Lesions
por: Krześlak, Anna, et al.
Publicado: (2011)

Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins.
por: Franzén, B., et al.
Publicado: (1996)

Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes
por: Saeed-Vafa, Daryoush, et al.
Publicado: (2021)

Role of diffusion MRI in characterizing benign and malignant breast lesions
por: Palle, Lalitha, et al.
Publicado: (2009)

Tumor-Derived Matrix Metalloproteinase-13 (MMP-13) Expression in Benign and Malignant Breast Lesions
por: Ameli, Fereshteh, et al.
Publicado: (2021)

All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4
por: Shousha, Sami, et al.
Publicado: (2019)

Radiofrequency for benign and malign thyroid lesions
por: Rangel, Leonardo, et al.
Publicado: (2020)

Acoustic Radiation Force Impulse Imaging in Benign and Malignant Breast Lesions
por: Jayaraman, Jayapriya, et al.
Publicado: (2017)

Caveolin-1 Expression in Different Types of Psoriatic Lesions: Analysis of 66 Cases
por: Zhang, Feng, et al.
Publicado: (2014)

Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study
por: Tőkés, Anna-Mária, et al.
Publicado: (2005)

Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast
por: Boström, Pia, et al.
Publicado: (2012)

Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status
por: Li, Xiaojun, et al.
Publicado: (2023)

Comparative Expression of RAGE and SOX2 in Benign and Malignant Prostatic Lesions
por: Aboushousha, Tarek, et al.
Publicado: (2019)

Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women.
por: Bhathal, P. S., et al.
Publicado: (1985)

Value of diffusion-weighted imaging in differentiating benign from malignant breast lesions
por: Stijven, S, et al.
Publicado: (2009)

Diagnostic investigation of breast magnetic resonance imaging in malignant and benign mass lesions
por: Gity, Masoumeh, et al.
Publicado: (2016)

Peripheral blood transcriptome identifies high-risk benign and malignant breast lesions
por: Hou, Hong, et al.
Publicado: (2020)

Kinetic patterns of benign and malignant breast lesions on contrast enhanced digital mammogram
por: Huang, Jer-Shyung, et al.
Publicado: (2020)

Tabu Search and Machine-Learning Classification of Benign and Malignant Proliferative Breast Lesions
por: Dhahri, Habib, et al.
Publicado: (2020)

Shear wave versus strain elastography in the differentiation of benign and malignant breast lesions
por: GÜRÜF, Aykut, et al.
Publicado: (2019)

MRI-Based Machine Learning in Differentiation Between Benign and Malignant Breast Lesions
por: Zhao, Yanjie, et al.
Publicado: (2021)

Utility of Ultrasound Strain Elastography to Differentiate Benign from Malignant Lesions of the Breast
por: Kanagaraju, Vikrant, et al.
Publicado: (2020)

Application of Diffusion Weighted Imaging Techniques for Differentiating Benign and Malignant Breast Lesions
por: He, Muzhen, et al.
Publicado: (2021)

Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling
por: Bernemann, Christof, et al.
Publicado: (2014)

Role of metallothioneins in benign and malignant thyroid lesions
por: Pula, Bartosz, et al.
Publicado: (2012)

Diagnostic Snapshot: Aggressive Malignancy or Benign Lesion?
por: Goforth, Paige M.
Publicado: (2014)

Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer
por: Sagara, Y, et al.
Publicado: (2004)

The Rare Benign Lesion That Mimics a Malignant Tumor in Breast Parenchyma: Nodular Fasciitis of the Breast
por: Erinanc, Hilal, et al.
Publicado: (2018)

Differentiation of Benign and Malignant Breast Lesions Using ADC Values and ADC Ratio in Breast MRI
por: Tsvetkova, Silvia, et al.
Publicado: (2022)

Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance
por: Wang, Lingxiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mq6u24g9cm61dkp3t2utqkgsp8